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QTc interval was longer in patients with SSc than in control subjects.
In addition they conclude that QT dispersion and QTc dispersion were
significantly increased in SSc patients withmyocardial resting perfusion
defects [1–2].
De Luca et al. reported aQTc prolongation only in 11% of SSc-patients
with new onset of suggestive symptoms of cardiac involvement, such asQTc prolongation
Arrhythmia
Cardiac involvementDear Dr De Luca,
In systemic sclerosis (SSc) QTc interval prolongation was report-
ed from 14 to 25% of patients [1–3]. Massie et al. in a cohort of 689
SSc patients reported a prolonged QTc interval (N440 ms) in 25% of
patients. However, in both univariate and multivariate analyses,
QTc prolongationwas associated with longer disease duration, great-
er disease severity and the presence of anti-RNA polymerase III anti-
bodies. The authors did not find an association between prolonged
QTc and anti- Ro antibodies. In the study, the authors reported a
mean value of QTc of 422± 47ms [1]. Themedian value of QTc inter-
val in our group is 447 ms (414–566). Our data of QTc interval are
similar to data reported by Massie et al., although in a higher
percentage of SSc patients. Massie et al. concluded that QTc prolon-
gation, which is common in SSc may be due, at least in part, to myo-
cardial fibrosis, which may prolong the ventricular recovery time by
disturbing the coronary microcirculation [1]. Foocharoen et al. re-
ported a prolonged QTc in 14.6% of 103 asymptomatic cardiac SSc pa-
tients. The QTc prolongation correlated with skin involvement and
Raynaud's phenomenon [4].edicine, Sapienza University of
te).Sgreccia et al. demonstrated in asymptomatic cardiac patients that
dyspnea, palpitations, chest pain, and/or signs of heart failure. We are
surprised because it is the lowest percentage reported of QTc prolonga-
tion in patients with cardiac involvement [5].
Io our paper we demonstrated only that QTc was longer in SSc pa-
tients than healthy controls. We suppose that microvascular damage
is present early in myocardium of SSc patients and it may be the patho-
genic mechanism of autonomic dysfunction and arrhythmias. We have
just formulated a hypothesis about correlation between QTc prolonga-
tion and digital microvascular damage. Future largest studies are need-
ed to evaluate this correlation.
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